We describe principles and initial clinical findings regarding a novel application of topographically customized collagen cross-linking (CXL) aiming to achieve a modest, nevertheless predictable hyperopic and presbyopic refractive changes. CXL is implemented in a specific, annular section mid-peripherally, employing differential response and biomechanical change, inducing central corneal steepening and asphericity changes. Efficacy, safety, and predictability of this procedure are also presented. This non-laser, minimally invasive technique may be applied either with epithelial removal, offering a more stable result or with a purely non-ablative and non-incisional approach, offering a minimally invasive alternative.